Skip to main content
Benjamin Segal, MD, Neurology, Columbus, OH, Ohio State University Wexner Medical Center

BenjaminMatthewSegalMD

Neurology • Columbus, OH

Neuroimmunology/Multiple Sclerosis

Chair, Department of Neurology; Director, The Neuroscience Research Institute; Co-director, The Neurological Institute

Join to view full profile

Dr. Segal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Segal's full profile

Already have an account?

Summary

  • Benjamin Segal, MD, is a leader and clinician-scientist at The Ohio State University Wexner Medical Center and The Ohio State University College of Medicine. He is Chair of the Department of Neurology, Director of the Neuroscience Research Institute, and co-director of the Neurological Institute (NI). The NI combines five neuroscience-related specialties into one integrated program in order to accelerate innovation and promote collaborations in patient care and research. As the Stanley D. and Joan H. Ross Endowed Professor of Neurology, Dr. Segal is actively involved in training the next generation of physicians and scientists who treat and study neurological disorders. At the international level, he serves on the Board of Directors of the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS). He is founder and organizer of the annual ACTRIMS Neurology Resident and Young Investigator Summits, and he chaired the Scientific Program Committee of the 2020 ACTRIMS/ECTRIMS meeting, which is the largest international academic meeting on MS and related disorders. Named among the Best Doctors in America for over ten years, Dr. Segal is internationally recognized for his work in Multiple Sclerosis (MS) and neuroimmunology. With annual NIH funding for his ongoing research programs in excess of $1.3 million, his discoveries have contributed to the basic understanding of the pathogenesis of MS and similar diseases. Dr. Segal has received innumerable awards, including the prestigious Harry Weaver Neuroscience Scholar award from the National Multiple Sclerosis Society and the Commendation Medal for Excellence from the Public Health Service. He has lectured nationally and internationally and served on multiple NIH study sections, including co-chairing the major review panel in his field. He holds several patents and is a member of every major organization in neurology.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1989 - 1992
  • Weill Cornell Medical College - New York Presbyterian Hospital/Memorial Sloan Kettering
    Weill Cornell Medical College - New York Presbyterian Hospital/Memorial Sloan Kettering Residency, Neurology, 1989 - 1992
  • University of Chicago
    University of ChicagoInternship, Internal Medicine, 1988 - 1989
  • The Warren Alpert Medical School of Brown University
    The Warren Alpert Medical School of Brown UniversityClass of 1988
  • Brown University
    Brown UniversityBachelors of Science, magna cum laude, 1980 - 1984

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2019 - 2026
  • MI State Medical License
    MI State Medical License 2007 - 2020
  • NY State Medical License
    NY State Medical License 1991 - 2018
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Chair, Scientific Programs ACTRIMS-ECTRIMS
  • Founder and Chair, ACTRIMS Young Investigators and Neurology Residents Summit
  • Chair, Scientific Program Committee 8th Joint ACTRIMS-ECTRIM meeting, 2020
  • Join now to see all

Publications & Presentations

PubMed

Lectures

  • Pathogenic and protective neutrophil subsets in neuroinflammation 
    Quebec, CA - 4/11/2019
  • Characterization of a unique granulocyte with neuroprotective and neuroregenerative properties 
    Detroit, MI - 1/18/2019
  • Update on the Diagnosis and Treatment of Multiple Sclerosis 
    Las Vegas, NV - 11/9/2018
  • Join now to see all

Press Mentions

  • Top Stories from ACTRIMS: Awareness of COVID-19, Inflammation’s Impact on Treatment
    Top Stories from ACTRIMS: Awareness of COVID-19, Inflammation’s Impact on TreatmentMarch 12th, 2021
  • Research at OSU Could Lead to Breakthroughs for Neurological Diseases
    Research at OSU Could Lead to Breakthroughs for Neurological DiseasesNovember 20th, 2020
  • Incurable Neurological Diseases: Moving Toward Treatments
    Incurable Neurological Diseases: Moving Toward TreatmentsNovember 6th, 2020
  • Join now to see all

Grant Support

  • Preclinical Studies Of A Madcam-Fc Fusion Protein In Multiple SclerosisVeterans Affairs2012
  • The Regulation Of Myeloid Cell Development And Mobilization During Autoimmune DEMNational Institute Of Neurological Disorders And Stroke2010–2012
  • Lymphoid Chemokines In Autoimmune EncephalomyelitisNational Institute Of Neurological Disorders And Stroke2007
  • Lymphoid Chemokines In Autoimmune EncephalomyelitisNational Institute Of Neurological Disorders And Stroke2004–2007
  • Cytokine Regulation Of Mature Myelin-Specific T CellsNational Institute Of Neurological Disorders And Stroke2001–2004

Professional Memberships

Hospital Affiliations

Dr. Benjamin Segal, Dr. Benjamin Segal, MD, Dr. B Segal, Dr. Benjamin Matthew Segal